Calculated based on number of publications stored in Pure and citations from Scopus
20112022

Research activity per year

Personal profile

Personal profile

Dr. Mahinur Mattohti is an Assistant Professor of Cancer Epigenomics at Houston Methodist Research Institute (HMRI), Weill Cornell Medical College. Prior to joining HMRI as faculty in September 2022, she completed her postdoctoral fellowship and held an instructor position at the University of Texas MD Anderson Cancer Center. Dr. Mattohti’s work focuses on understanding how epigenetic changes drive tumorigenesis, disease progression, and the development of therapy resistance, with the goal of leveraging these insights to design innovative therapeutic strategies. 

Research interests

Dr. Mattohti’s laboratory combines experimental, computational, and high-throughput technologies to study and modulate epigenetic changes in cancer. The overarching goals of the lab are to: (1) identify the epigenetic drivers of cancer development and progression, (2) uncover the epigenetic alterations and mechanisms underlying resistance to targeted and immunotherapies, and (3) exploit novel epigenetic targets to develop innovative therapeutic strategies.

Education/Academic qualification

Research Doctorate, Cancer Genomics, Beth Israel Deaconess Medical Center

Postdoctoral Fellowship, Cancer Epigenomics, MD Anderson Cancer Center

Postdoctoral Associate, Epigenetics, Massachusetts General Cancer Center

External positions

Assistant Professor of Cancer Biology in Surgery, Weill Cornell Medicine

Jun 1 2023 → …

Research Area Keywords

  • Cancer

Free-text keywords

  • Epigenomics
  • Transcriptional regulation
  • Immunotherapy

Fingerprint

Dive into the research topics where Mahinur Mattohti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or